The Patent Finder

Immune Design Corp.

Also on record
Records under this name other than the patents Immune Design Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.

Showing 1 to 5 of 5 · Back to Immune Design Corp.

PatentTitleStatus Expires Confidence
US 11,365,230Compositions comprising lentiviral vectors expressing IL-12 and methods of use thereof
Lapsed on the fee record
Ended Jun 21, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jun 21, 2026From the USPTO record
US 11,135,283Retroviral vector for the administration and expression of replicon RNA expressing heterologous nucleic acids
Lapsed on the fee record
Ended Oct 5, 2025 · From the USPTO record
Lapsed on the fee recordEnded Oct 5, 2025From the USPTO record
US 9,713,635Materials and methods for producing improved lentiviral vector particles
Lapsed on the fee record
Ended Jul 25, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jul 25, 2025From the USPTO record
US 10,993,999Materials and methods for producing improved lentiviral vector particles
Lapsed on the fee record
Ended May 4, 2025 · From the USPTO record
Lapsed on the fee recordEnded May 4, 2025From the USPTO record
US 8,323,662Methods useful for generating highly mannosylated pseudotyped lentiviral vector particles comprising a Vpx protein
Lapsed on the fee record
Ended Dec 4, 2024 · From the USPTO record
Lapsed on the fee recordEnded Dec 4, 2024From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited